|
Kulcharyk, P A; Heinecke, J W (2001) Hypochlorous acid produced by the myeloperoxidase system of human phagocytes induces covalent cross-links between DNA and protein. Biochemistry 40:3648-56
|
|
Brennan, M L; Anderson, M M; Shih, D M et al. (2001) Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 107:419-30
|
|
Henderson, J P; Byun, J; Mueller, D M et al. (2001) The eosinophil peroxidase-hydrogen peroxide-bromide system of human eosinophils generates 5-bromouracil, a mutagenic thymine analogue. Biochemistry 40:2052-9
|
|
Henderson, J P; Byun, J; Williams, M V et al. (2001) Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation. J Biol Chem 276:7867-75
|
|
Sugiyama, S; Okada, Y; Sukhova, G K et al. (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-91
|
|
Henderson, J P; Byun, J; Williams, M V et al. (2001) Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc Natl Acad Sci U S A 98:1631-6
|
|
Kirk, E A; Dinauer, M C; Rosen, H et al. (2000) Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20:1529-35
|
|
Heller, J I; Crowley, J R; Hazen, S L et al. (2000) p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J Biol Chem 275:9957-62
|
|
Schoneich, C; Viner, R I; Ferrington, D A et al. (1999) Age-related chemical modification of the skeletal muscle sarcoplasmic reticulum Ca-ATPase of the rat. Mech Ageing Dev 107:221-31
|
|
Anderson, M M; Requena, J R; Crowley, J R et al. (1999) The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104:103-13
|
Showing the most recent 10 out of 33 publications
